Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

Amgen at Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

Amgen brings 3 presentations to Discovery on Target 2026 in Boston. Its program centres on degraders, from making molecular glue discovery an industrial process to new chemistries and cellular pathways for next-generation degraders. It also weighs a modality-agnostic approach to difficult drug targets.

OrganizationDiscovery on Target 2026 Attendance
Amgen
Thousand Oaks, CA
Large pharma
Global biotechnology company with medicines in oncology, inflammation, cardiovascular and bone disease.
Talk
Tue Sep 29
2:50pm–3:20pm
Industrializing Molecular Glue Discovery
Novel Drug Modalities
Panel
Tue Sep 29
5:00pm–6:00pm
Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach
Plenary · with Drug Hunter, Bristol Myers Squibb, Novartis +3 more
Novel drug modalitiesInnovative discovery technologies
Panel
Wed Sep 30
7:30am–8:15am
Exploring New Chemistries and Cellular Pathways for Developing Next-Generation Degraders
Novel Drug Modalities · with TRIMTECH Therapeutics, The Institute of Cancer Research

Explore the full Discovery on Target 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full Discovery on Target 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Amgen

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction